Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Gross Profit 2006-2019 | BIIB

Biogen annual/quarterly gross profit history and growth rate from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Biogen gross profit for the quarter ending December 31, 2019 was $3.224B, a 6.14% increase year-over-year.
  • Biogen gross profit for the twelve months ending December 31, 2019 was $12.423B, a 6.75% increase year-over-year.
  • Biogen annual gross profit for 2019 was $12.423B, a 6.75% increase from 2018.
  • Biogen annual gross profit for 2018 was $11.637B, a 9.33% increase from 2017.
  • Biogen annual gross profit for 2017 was $10.644B, a 6.76% increase from 2016.
  
Biogen Annual Gross Profit
(Millions of US $)
2019 $12,423
2018 $11,637
2017 $10,644
2016 $9,970
2015 $9,523
2014 $8,532
2013 $6,075
2012 $4,971
2011 $4,582
2010 $4,316
2009 $3,995
2008 $3,696
2007 $2,836
2006 $2,409
2005 $2,049
Biogen Quarterly Gross Profit
(Millions of US $)
Q4 2019 $3,224
Q3 2019 $3,170
Q2 2019 $3,140
Q1 2019 $2,888
Q4 2018 $3,038
Q3 2018 $2,978
Q2 2018 $2,936
Q1 2018 $2,685
Q4 2017 $2,798
Q3 2017 $2,708
Q2 2017 $2,712
Q1 2017 $2,426
Q4 2016 $2,494
Q3 2016 $2,539
Q2 2016 $2,524
Q1 2016 $2,414
Q4 2015 $2,507
Q3 2015 $2,468
Q2 2015 $2,306
Q1 2015 $2,243
Q4 2014 $2,343
Q3 2014 $2,209
Q2 2014 $2,130
Q1 2014 $1,851
Q4 2013 $1,707
Q3 2013 $1,593
Q2 2013 $1,493
Q1 2013 $1,281
Q4 2012 $1,284
Q3 2012 $1,246
Q2 2012 $1,282
Q1 2012 $1,159
Q4 2011 $1,187
Q3 2011 $1,186
Q2 2011 $1,108
Q1 2011 $1,100
Q4 2010 $1,119
Q3 2010 $1,080
Q2 2010 $1,106
Q1 2010 $1,012
Q4 2009 $1,027
Q3 2009 $1,027
Q2 2009 $1,003
Q1 2009 $938
Q4 2008 $968
Q3 2008 $985
Q2 2008 $901
Q1 2008 $841
Q4 2007 $806
Q3 2007 $708
Q2 2007 $689
Q1 2007 $634
Q4 2006 $646
Q3 2006 $637
Q2 2006 $582
Q1 2006 $544
Q4 2005 $520
Q3 2005 $507
Q2 2005 $535
Q1 2005 $488
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $58.597B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.020B 14.98
CSL (CSLLY) Australia $101.716B 0.00
Gilead Sciences (GILD) United States $84.765B 10.91
Vertex Pharmaceuticals (VRTX) United States $63.547B 57.67
Illumina (ILMN) United States $44.168B 45.66
Regeneron Pharmaceuticals (REGN) United States $43.913B 18.60
Alexion Pharmaceuticals (ALXN) United States $22.702B 10.56
Seattle Genetics (SGEN) United States $20.383B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.943B 38.50
BioMarin Pharmaceutical (BMRN) United States $16.105B 0.00
Genmab (GNMSF) Denmark $15.176B 48.81
Alnylam Pharmaceuticals (ALNY) United States $14.987B 0.00
Galapagos (GLPG) Belgium $14.255B 36.73
Exact Sciences (EXAS) United States $13.326B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.443B 0.00
Sarepta Therapeutics (SRPT) United States $9.176B 0.00
QIAGEN (QGEN) Netherlands $8.414B 25.91
Guardant Health (GH) United States $8.209B 0.00
Bio-Techne Corp (TECH) United States $8.011B 54.82
BioNTech SE (BNTX) Germany $7.326B 0.00
Ascendis Pharma (ASND) Denmark $6.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.905B 0.00
Reata Pharmaceuticals (RETA) United States $6.773B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.750B 17.16
Exelixis (EXEL) United States $6.527B 18.36
Amarin (AMRN) Ireland $6.383B 0.00
Moderna (MRNA) United States $6.239B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.142B 0.00
Repligen (RGEN) United States $5.264B 96.31
Acceleron Pharma (XLRN) United States $5.035B 0.00
China Biologic Products (CBPO) China $4.598B 25.90
Bluebird Bio (BLUE) United States $4.584B 0.00
Adaptive Biotechnologies (ADPT) United States $4.203B 0.00
MorphoSys AG (MOR) Germany $3.896B 0.00
Mirati Therapeutics (MRTX) United States $3.706B 0.00
Blueprint Medicines (BPMC) United States $3.672B 0.00
Zai Lab (ZLAB) China $3.650B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
Immunomedics (IMMU) United States $3.486B 0.00
NeoGenomics (NEO) United States $3.456B 183.89
CRISPR Therapeutics AG (CRSP) Switzerland $3.454B 58.51
Momenta Pharmaceuticals (MNTA) United States $3.363B 0.00
Emergent Biosolutions (EBS) United States $3.334B 23.31
Alkermes (ALKS) Ireland $3.224B 255.38
Genmab (GMAB) Denmark $3.220B 12.63
Halozyme Therapeutics (HALO) United States $3.149B 0.00
MyoKardia (MYOK) United States $3.142B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.074B 0.00
UniQure (QURE) Netherlands $2.774B 0.00
Amicus Therapeutics (FOLD) United States $2.760B 0.00
Insmed (INSM) United States $2.719B 0.00
Arena Pharmaceuticals (ARNA) United States $2.667B 6.20
Denali Therapeutics (DNLI) United States $2.379B 0.00
Epizyme (EPZM) United States $2.321B 0.00
Principia Biopharma (PRNB) United States $2.290B 0.00
Fate Therapeutics (FATE) United States $2.219B 0.00
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Alector (ALEC) United States $2.059B 0.00
REGENXBIO (RGNX) United States $1.977B 0.00
Zymeworks (ZYME) Canada $1.829B 0.00
Ligand Pharmaceuticals (LGND) United States $1.780B 51.97
Akcea Therapeutics (AKCA) United States $1.732B 0.00
Arvinas (ARVN) United States $1.711B 0.00
Coherus BioSciences (CHRS) United States $1.578B 0.00
Myriad Genetics (MYGN) United States $1.483B 26.17
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Zealand Pharma (ZEAL) Denmark $1.474B 0.00
Zealand Pharma (ZLDPF) Denmark $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Intra-Cellular Therapies (ITCI) United States $1.361B 0.00
Editas Medicine (EDIT) United States $1.349B 0.00
Revance Therapeutics (RVNC) United States $1.244B 0.00
Athenex (ATNX) United States $1.193B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.187B 0.00
Twist Bioscience (TWST) United States $1.174B 0.00
PHARMA MAR SA (PHMMF) Spain $1.029B 0.00
Adverum Biotechnologies (ADVM) United States $1.017B 0.00
Mesoblast (MESO) Australia $0.931B 0.00
Cytokineticsorporated (CYTK) United States $0.915B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.874B 0.00
DBV Technologies S.A (DBVT) France $0.874B 0.00
Vericel (VCEL) United States $0.851B 317.17
Codexis (CDXS) United States $0.823B 0.00
Heska (HSKA) United States $0.805B 205.60
Cellectis S.A (CLLS) France $0.797B 0.00
Intrexon (PGEN) United States $0.768B 0.00
Retrophin (RTRX) United States $0.738B 0.00
ANI Pharmaceuticals (ANIP) United States $0.736B 12.56
Arcus Biosciences (RCUS) United States $0.731B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.716B 6.02
Cara Therapeutics (CARA) United States $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.688B 0.00
GENFIT S.A (GNFT) France $0.677B 0.00
Kadmon Holdings (KDMN) United States $0.655B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.632B 0.00
Cel-Sci (CVM) United States $0.620B 0.00
Bellus Health (BLU) Canada $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.599B 20.49
Clovis Oncology (CLVS) United States $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.590B 0.00
NantKwest (NK) United States $0.586B 0.00
AC Immune SA (ACIU) Switzerland $0.568B 13.13
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.544B 0.00
Compugen (CGEN) Israel $0.539B 0.00
Agenus (AGEN) United States $0.521B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.473B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
Sorrento Therapeutics (SRNE) United States $0.445B 0.00
Mersana Therapeutics (MRSN) United States $0.444B 0.00
AnaptysBio (ANAB) United States $0.435B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.432B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.423B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.414B 0.00
Dynavax Technologies (DVAX) United States $0.412B 0.00
Precision BioSciences (DTIL) United States $0.409B 0.00
Avid Bioservices (CDMO) United States $0.407B 0.00
Pfenex (PFNX) United States $0.407B 0.00
PDL BioPharma (PDLI) United States $0.396B 9.91
Gritstone Oncology (GRTS) United States $0.372B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Inovio Pharmaceuticals (INO) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.356B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 0.00
WAVE Life Sciences (WVE) Singapore $0.333B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
OSMOTICA PHARM (OSMT) United States $0.313B 0.00
MannKind (MNKD) United States $0.312B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Syros Pharmaceuticals (SYRS) United States $0.311B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
Starpharma Holdings (SPHRY) Australia $0.302B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.297B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.276B 0.00
Kamada (KMDA) Israel $0.274B 11.39
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
VBI Vaccines (VBIV) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
IVERIC Bio (ISEE) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
Geron (GERN) United States $0.256B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.251B 0.00
Protagonist Therapeutics (PTGX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Kala Pharmaceuticals (KALA) United States $0.240B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Prometic Life Sciences (LMNL) Canada $0.228B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.225B 0.00
Alcobra (ARCT) United States $0.223B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.223B 11.46
Pieris Pharmaceuticals (PIRS) United States $0.216B 0.00
Arbutus Biopharma (ABUS) Canada $0.212B 0.00
Cerecor (CERC) United States $0.211B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.211B 0.00
Affimed (AFMD) Germany $0.209B 0.00
Theratechnologies (THTX) Canada $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
VolitionRX (VNRX) Singapore $0.205B 0.00
TELA Bio (TELA) United States $0.200B 0.00
Athersys (ATHX) United States $0.199B 0.00
Five Prime Therapeutics (FPRX) United States $0.195B 0.00
Fortress Biotech (FBIO) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 4.99
Spero Therapeutics (SPRO) United States $0.184B 0.00
Exicure (XCUR) United States $0.183B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Northwest Biotherapeutics (NWBO) United States $0.166B 0.00
CorMedix Inc (CRMD) United States $0.166B 0.00
Selecta Biosciences (SELB) United States $0.161B 0.00
Aptinyx (APTX) United States $0.160B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Verastem (VSTM) United States $0.156B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
ARAVIVE, INC (ARAV) United States $0.143B 0.00
Palatin Technologies (PTN) United States $0.141B 3.85
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
OvaScience (MLND) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Prima BioMed (IMMP) Australia $0.105B 0.00
Applied Genetic Technologies (AGTC) United States $0.104B 0.00
Proteostasis Therapeutics (PTI) United States $0.101B 0.00
Happiness Biotech Group (HAPP) China $0.100B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Emmaus Life Sciences (EMMA) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Synlogic (SYBX) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.084B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 5.05
Acorda Therapeutics (ACOR) United States $0.075B 0.00
Trevena (TRVN) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Celsion (CLSN) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
IBio (IBIO) United States $0.026B 0.00
VIVUS (VVUS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00